𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hypothermic Effects of Dopamine D3 Receptor Agonists in the Island of Calleja Magna. Potentiation by D1 Activation

✍ Scribed by Samir Barik; Renaud De Beaurepaire

Book ID
114103868
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
224 KB
Volume
60
Category
Article
ISSN
0091-3057

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

D1 dopamine receptors mediate neurolepti
D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja
✍ David Wirtshafter πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 158 KB

Systemic injections of the selective, full, D 1 agonists A-77636 and SKF-82958 induced pronounced Fos-like immunoreactivity in the islands of Calleja in the olfactory tubercle of intact rats. Fos expression in this region could also be induced by injections of the D 2 -like dopamine antagonist raclo

Antiparkinsonian effects of the novel D3
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors
✍ Michael P. Hill; Paula Ravenscroft; Steven G. McGuire; Jonathan M. Brotchie; Ala πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

L-dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor agonists such as the novel agent S32504, since they exert antiparkinsonian properties in the absence of dyskinesia. An important question concerns the roles of D2 vs. D3 recept